RiverVest Venture Fund IV L.P. 13D and 13G filings for Xilio Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-11-05 12:54 pm Purchase | 2021-10-26 | 13D | Xilio Therapeutics, Inc. XLO | RiverVest Venture Fund IV L.P. | 1,441,444 5.400% | 1,441,444 (New Position) | Filing |